Quantitative Analysis of the Effect of Neuromuscular Blockade on Motor-Evoked Potentials in Patients Undergoing Brain Tumor Removal Surgery: A Prospective, Single-Arm, Open-Label Observational Study

被引:0
|
作者
Chae, Dongwoo [1 ]
Kim, Hyun-Chang [2 ,3 ]
Park, Hun Ho [4 ]
Yoo, Jihwan [4 ]
Park, Yoon Ghil [5 ]
Kwak, Kyu Wan [5 ]
Kim, Dawoon [5 ]
Park, Jinyoung [5 ]
Han, Dong Woo [2 ,3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Pharmacol, 50 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, 50 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Anesthesia & Pain Res Inst, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea
[4] Yonsei Univ, Gangnam Severance Hosp, Brain Tumor Ctr, Dept Neurosurg,Coll Med, 211 Eonju Ro, Seoul 06273, South Korea
[5] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Rehabil Med, 211 Eonju Ro, Seoul 06273, South Korea
关键词
brain neoplasm; electric impedance; motor-evoked potential; neuromuscular blockers; transcranial magnetic stimulation; TRANSCRANIAL ELECTRICAL-STIMULATION; ROCURONIUM;
D O I
10.3390/jcm13154281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We aimed to elucidate the quantitative relationship between the neuromuscular blockade depth and intraoperative motor-evoked potential amplitudes. Methods: This prospective, single-arm, open-label, observational study was conducted at a single university hospital in Seoul, Korea, and included 100 adult patients aged >= 19 years undergoing brain tumor removal surgery under general anesthesia. We measured the neuromuscular blockade degree and motor-evoked potential amplitude in the deltoid, abductor pollicis brevis, tibialis anterior, and abductor hallucis muscles until dural opening. Results: The pharmacokinetic-pharmacodynamic model revealed the exposure-response relationship between the rocuronium effect-site concentration and motor-evoked potential amplitudes. The mean motor-evoked potential amplitudes decreased proportionally with increasing neuromuscular blockade depth. As the mean amplitude increased, the coefficient of variation decreased bi-exponentially. The critical ratio of the first evoked response to the train-of-four stimulation (T1)/control response (Tc) thresholds beyond which the coefficient of variation exhibited minimal change were found to be 0.63, 0.65, 0.68, and 0.63 for the deltoid, abductor pollicis brevis, tibialis anterior, and abductor hallucis muscles, respectively. Conclusions: Our results reveal that the motor-evoked potential amplitude exhibits deterioration proportional to the degree of neuromuscular blockade. In light of the observed bi-exponential decline of the coefficient of variation with the motor-evoked potential amplitude, we recommend maintaining a T1/Tc ratio higher than 0.6 for partial neuromuscular blockade.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Effects of galcanezumab on central sensitization in migraine patients: A prospective, open-label, single-arm multicenter study using validated central sensitization inventory
    Danno, Daisuke
    Imai, Noboru
    Kitamura, Shigekazu
    Ishizaki, Kumiko
    Kikui, Shoji
    Takeshima, Takao
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [42] A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancer
    Feng, J.
    Shen, B.
    Xu, J.
    Wang, Q.
    Ling, G.
    Mao, Y.
    Cai, M.
    Yang, Y.
    Mei, J.
    Han, Z.
    Wu, Y.
    Shi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S913 - S913
  • [43] Apatinib for patients (pts) with advanced soft tissue sarcoma (STS) after chemotherapy: A prospective, open-label, single-arm, multicentered study.
    Hu, Haiyan
    Yao, Yang
    Fan, Zhengfu
    Zhang, Hongmei
    Chen, Jing
    Zhang, Xing
    Chen, Yong
    Qu, Guofan
    Huang, Gang
    Zhou, Yuhong
    Yu, Wenxi
    Wang, Xiaowen
    Zhuang, Rongyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] SARILUMAB AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 12-WEEK TREATMENT RESULTS FROM A MULTICENTER, OPEN-LABEL, PROSPECTIVE, SINGLE-ARM OBSERVATIONAL STUDY
    Kivitz, A.
    Gottenberg, J. E.
    Bergman, M.
    Iglesias-Rodriguez, M.
    St John, G.
    Qiu, C.
    Van Hoogstraten, H.
    Bessette, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1446 - 1446
  • [45] Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment
    Mathai, Stephen C.
    Minai, Omar
    Sullivan, Sean D.
    Lerner, Debra
    Levine, Deborah
    RESPIRATORY MEDICINE, 2017, 122 : S23 - S27
  • [46] Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study
    Wan, Zhikai
    Tao, Ran
    Hui, Jiangjin
    Liu, Xiang
    Peng, Xiaorong
    Guo, Yongzheng
    Zhu, Xueling
    Huang, Ying
    Zhu, Biao
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [47] Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study
    Zhikai Wan
    Ran Tao
    Jiangjin Hui
    Xiang Liu
    Xiaorong Peng
    Yongzheng Guo
    Xueling Zhu
    Ying Huang
    Biao Zhu
    Journal of Neuroinflammation, 20
  • [48] Anlotinib plus hormone therapy in patients with platinum-resistant recurrent ovarian cancer: A prospective, single-arm, open-label, phase II study
    Wang, Xipeng
    Li, Jiarui
    Zhang, Ping
    Wang, Yizhi
    Lu, Xin
    Xu, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] A prospective, open-label, single-arm clinical trial of the effects of natalizumab on measures of ambulation in relapsing-remitting multiple sclerosis patients: the TIMER study
    Voloshyna, N.
    Nechrych, T.
    You, X.
    Belachew, S.
    Paes, D.
    JOURNAL OF NEUROLOGY, 2013, 260 : S67 - S67
  • [50] A Prospective Open-label Single-Arm Phase II Study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patients
    Varga, Z
    de Mulder, P
    Kruit, W
    Hegele, A
    Hofmann, R
    Lamers, C
    Warnaar, S
    Mala, C
    Ullrich, S
    Mulders, P
    FOLIA BIOLOGICA, 2003, 49 (02) : 74 - 77